369 related articles for article (PubMed ID: 28379297)
21. MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.
Craze ML; Cheung H; Jewa N; Coimbra NDM; Soria D; El-Ansari R; Aleskandarany MA; Wai Cheng K; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Br J Cancer; 2018 Jan; 118(2):258-265. PubMed ID: 29169183
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
[TBL] [Abstract][Full Text] [Related]
23. Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome.
Xiao S; Li S; Yuan Z; Zhou L
Ann Transl Med; 2020 Aug; 8(15):937. PubMed ID: 32953737
[TBL] [Abstract][Full Text] [Related]
24. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
25. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation.
Guo J; Cheng X; Tian Y; Li B; Zhang X; Gao X; An Y
Reprod Biol; 2021 Sep; 21(3):100534. PubMed ID: 34271243
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.
Kuo CL; Chou HY; Chiu YC; Cheng AN; Fan CC; Chang YN; Chen CH; Jiang SS; Chen NJ; Lee AY
Cancer Lett; 2020 Apr; 474():138-150. PubMed ID: 31987921
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1 (pyrroline-5-carboxylate reductase 1).
Li Z; Zhou X; Huang J; Xu Z; Xing C; Yang J; Zhou X
Bioengineered; 2021 Dec; 12(2):9766-9778. PubMed ID: 34696668
[TBL] [Abstract][Full Text] [Related]
29. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Bjørklund SS; Kristensen VN; Seiler M; Kumar S; Alnæs GI; Ming Y; Kerrigan J; Naume B; Sachidanandam R; Bhanot G; Børresen-Dale AL; Ganesan S
BMC Cancer; 2015 Jul; 15():524. PubMed ID: 26183823
[TBL] [Abstract][Full Text] [Related]
30. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
32. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
[TBL] [Abstract][Full Text] [Related]
33. Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Cai F; Miao Y; Liu C; Wu T; Shen S; Su X; Shi Y
Oncol Lett; 2018 Jan; 15(1):731-740. PubMed ID: 29403556
[TBL] [Abstract][Full Text] [Related]
34. Kindlin-2 links mechano-environment to proline synthesis and tumor growth.
Guo L; Cui C; Zhang K; Wang J; Wang Y; Lu Y; Chen K; Yuan J; Xiao G; Tang B; Sun Y; Wu C
Nat Commun; 2019 Feb; 10(1):845. PubMed ID: 30783087
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
[TBL] [Abstract][Full Text] [Related]
36. Sublethal endoplasmic reticulum stress caused by the mutation of immunoglobulin heavy chain-binding protein induces the synthesis of a mitochondrial protein, pyrroline-5-carboxylate reductase 1.
Jin H; Komita M; Koseki H; Aoe T
Cell Stress Chaperones; 2017 Jan; 22(1):77-85. PubMed ID: 27796797
[TBL] [Abstract][Full Text] [Related]
37. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions.
Westbrook RL; Bridges E; Roberts J; Escribano-Gonzalez C; Eales KL; Vettore LA; Walker PD; Vera-Siguenza E; Rana H; Cuozzo F; Eskla KL; Vellama H; Shaaban A; Nixon C; Luuk H; Lavery GG; Hodson DJ; Harris AL; Tennant DA
Cell Rep; 2022 Feb; 38(5):110320. PubMed ID: 35108535
[TBL] [Abstract][Full Text] [Related]
38. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
Christensen EM; Patel SM; Korasick DA; Campbell AC; Krause KL; Becker DF; Tanner JJ
J Biol Chem; 2017 Apr; 292(17):7233-7243. PubMed ID: 28258219
[TBL] [Abstract][Full Text] [Related]
39. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of Pycr1 and Pycr2 in mice.
Stum MG; Tadenev ALD; Seburn KL; Miers KE; Poon PP; McMaster CR; Robinson C; Kane C; Silva KA; Cliften PF; Sundberg JP; Reinholdt LG; John SWM; Burgess RW
Genetics; 2021 May; 218(1):. PubMed ID: 33734376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
